FINWIRES · TerminalLIVE
FINWIRES

マーケットチャット:ミネベアミツミがカンボジア事業を拡大、新たなライダー工場を開設

-- ミネベアミツミ(東証:6479)は、カンボジアを戦略的な生産拠点として発展させる計画で、新工場を活用して自動運転システム向けLiDAR部品を米国へ輸出する予定だと、日本経済新聞が火曜日に報じた。 同報道によると、プルサット州にある新工場は既に一部操業を開始しており、高精度センサーの需要増加に伴い生産量も増加する見込みだという。 同報道によれば、ミネベアミツミは、タイとの国境紛争による物流コストの上昇にもかかわらず、「タイプラスワン」戦略からの脱却を目指している。 同報道によると、ミネベアミツミはカンボジアの既存拠点の安定的な操業を維持しつつ、ベトナムと中国で代替サプライヤーを探しているという。 (マーケットチャッターのニュースは、世界中の市場関係者との会話に基づいています。この情報は信頼できる情報源に基づいていると考えられますが、噂や憶測が含まれる可能性があります。正確性は保証されません。)

Related Articles

Asia

Update: Origin Energy Reports Lower March Quarter Production; Shares Fall 3%

(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.

$ASX:ORG
Asia

Alterity Therapeutics Secures US FDA Support for ATH434 Phase Three Program

Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.

$ASX:ATH
Asia

Xinyuan Property Management's CFO Resigns

Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.

$HKG:1895